Selecting Translational Preclinical Models for Studying Inflammasomes

Time: 11:30 am
day: Day 2


  • Considerations for selecting the most appropriate model for studying inflammasomes based on disease pathology, genetic background, target tissue involvement and desired outcomes in different disease indications
  • Strategies for standardizing translation across laboratories and industries to improve reproducibility and reliability of preclinical data for comparison across the industry
  • Importance of selecting animal models that recapitulate human disease pathology to improve the predictiveness of preclinical studies and better align with clinical outcomes